A landmark study shows the 9-valent HPV vaccine cuts cancer risk in young males nearly in half, bolstering calls for gender-neutral vaccination. Separately, NIH research confirms a single vaccine dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results